
PMC:7346000 / 9331-9470
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
279 | 67-71 | Gene | denotes | IL-6 | Gene:3569 |
285 | 130-138 | Species | denotes | patients | Tax:9606 |
295 | 121-129 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T103 | 121-129 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T55 | 67-69 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T57 | 72-83 | Chemical | denotes | antagonists | http://purl.obolibrary.org/obo/CHEBI_48706 |
T58 | 88-98 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T51 | 0-139 | Sentence | denotes | For this reason, ongoing trials are addressing the combined use of IL-6 antagonists and antifungal prophylaxis in severe COVID-19 patients. |